福泰制药2024财年实现净利润-5.36亿美元,同比减少114.81%

市场透视
15 Feb

2月15日,福泰制药(VRTX.US)公布财报,公告显示公司2024财年净利润为-5.36亿美元,同比减少114.81%;其中营业收入为110.20亿美元,同比增加12.00%,每股基本收益为-2.08美元。从资产负债表来看,福泰制药(VRTX.US)总负债66.81亿美元,其中短期债务--,资产负债比为3.38,流动比率为2.70。机构评级:截至2025年2月15日,当前有28家机构对福泰制药...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10